Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD 33.93
-0.11 (-0.32%)
At close: Jan 20, 2026
Ansell Market Cap
Ansell has a market cap or net worth of 4.83 billion as of January 20, 2026. Its market cap has decreased by -1.42% in one year.
Market Cap
4.83B
Enterprise Value
5.73B
Revenue
3.06B
Ranking
n/a
PE Ratio
32.01
Stock Price
33.93
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 5.00B to 4.83B, a decrease of -3.22%. That is a compound annual growth rate of -0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.83B | -3.08% |
| Dec 31, 2025 | 4.99B | 1.96% |
| Dec 31, 2024 | 4.89B | 56.70% |
| Dec 29, 2023 | 3.12B | -12.08% |
| Dec 30, 2022 | 3.55B | -11.25% |
| Dec 31, 2021 | 4.00B | -10.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 85.10B |
| Pro Medicus | 19.76B |
| Cochlear | 17.57B |
| Sonic Healthcare | 11.40B |
| Ramsay Health Care | 8.43B |
| Telix Pharmaceuticals | 3.82B |
| Mesoblast | 3.28B |
| 4DMedical | 2.61B |